{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:55:27Z","timestamp":1792364127039,"version":"4.4.0"},"reference-count":36,"publisher":"American Association for Cancer Research (AACR)","issue":"5","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5U54MD007585-34"],"award-info":[{"award-number":["5U54MD007585-34"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["1UG3HG013553-01"],"award-info":[{"award-number":["1UG3HG013553-01"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016419","name":"Breast Cancer Research Foundation of Alabama","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Breast cancer is a heterogeneous disease composed of distinct molecular subtypes that influence prognosis and treatment response, with subtype discordance between primary and metastatic tumors contributing to therapeutic failure. Using GeoMx spatial transcriptomics, we profiled nonmetastatic primary tumors, metastatic primary tumors, and lymph node (LN) metastases to characterize transcriptional and immune\u2013spatial changes during disease progression. Comparative analysis revealed strong tumor microenvironment reprogramming across clinical states. In stromal regions of metastatic tumors, we observed enrichment of extracellular matrix remodeling, tumor-associated macrophage activity, and epithelial-to-mesenchymal transition\u2013related pathways. In epithelial compartments, nonmetastatic and LN tumors showed a secretory\u2013proliferative program, whereas primary metastatic tumors were enriched for antigen presentation and interferon (IFN) signaling. Immune deconvolution demonstrated distinct immune landscapes, with nonmetastatic tumors enriched for innate immune cells, primary metastatic tumors showing increased T- and B-cell infiltration, and LN metastases exhibiting an immunosuppressive microenvironment dominated by M2-like macrophages and memory B cells (P &amp;lt; 0.05). Subtype analysis revealed frequent triple-negative breast cancer (TNBC) subtype switching during LN metastasis, with 70% of cases transitioning from nonbasal subtypes to unspecified or immunomodulatory subtypes, both associated with poorer prognosis (HR = 1.8; 95% CI, 1.2\u20132.9). Spatial immune profiling further identified \u201cexcluded\u201d and \u201cignored\u201d tumors lacking T-cell infiltration, whereas \u201cinflamed\u201d tumors retained active cytotoxic immune responses. Integrating molecular subtype, immune infiltration, and spatial architecture, we developed a novel framework termed immuno-spatial molecular subtypes (ISMS), which captures TNBC heterogeneity and immune\u2013spatial plasticity across disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>TNBC progression is poorly understood, particularly how tumor and immune ecosystems evolve. By applying spatial transcriptomics on tissues, we uncover that nonmetastatic tumors displayed metabolic programs and a more coordinated immune\u2013proliferation balance. Metastatic primary showed stronger IFN and antigen-presentation programs, whereas LN metastases showed an immune-excluded niche. Our discovery that immune phenotypes diverge from canonical subtypes led to development of ISMS, a framework that captures TNBC plasticity more accurately than subtype alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0808","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:53:58Z","timestamp":1778230438000},"page":"1246-1260","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["TNBC Spatial Transcriptomic Analysis across Clinical States Reveals Subtype-Specific Networks and Immunosuppressive Niches"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6696-9290","authenticated-orcid":false,"given":"Fengyuan","family":"Huang","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0137n4m74","id-type":"ROR","asserted-by":"publisher"}],"name":"Tuskegee University 1 Center for Biomedical Research, , Tuskegee, Alabama."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6429-6125","authenticated-orcid":false,"given":"Nitish","family":"Kunte","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0137n4m74","id-type":"ROR","asserted-by":"publisher"}],"name":"Tuskegee University 1 Center for Biomedical Research, , Tuskegee, Alabama."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8097-6120","authenticated-orcid":false,"given":"Himani","family":"Khurana","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0137n4m74","id-type":"ROR","asserted-by":"publisher"}],"name":"Tuskegee University 1 Center for Biomedical Research, , Tuskegee, Alabama."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5420-9852","authenticated-orcid":false,"given":"Clayton C.","family":"Yates","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Oncology, John Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4403-2680","authenticated-orcid":false,"given":"Deepa","family":"Bedi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0137n4m74","id-type":"ROR","asserted-by":"publisher"}],"name":"Tuskegee University 1 Center for Biomedical Research, , Tuskegee, Alabama."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"2026060811114821100_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3121\/cmr.2008.825","article-title":"Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival","volume":"7","author":"Onitilo","year":"2009","journal-title":"Clin Med Res"},{"key":"2026060811114821100_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"key":"2026060811114821100_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","article-title":"Biological subtypes of breast cancer: prognostic and therapeutic implications","volume":"5","author":"Yersal","year":"2014","journal-title":"World J Clin Oncol"},{"key":"2026060811114821100_bib4","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3390\/pharmaceutics15071796","article-title":"Triple negative breast cancer treatment options and limitations: future outlook","volume":"15","author":"Obidiro","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026060811114821100_bib5","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"2026060811114821100_bib6","doi-asserted-by":"crossref","first-page":"14937","DOI":"10.3390\/ijms232314937","article-title":"Genetic heterogeneity, tumor microenvironment and immunotherapy in triple-negative breast cancer","volume":"23","author":"Kudelova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026060811114821100_bib7","doi-asserted-by":"crossref","first-page":"10232","DOI":"10.1038\/s41467-024-54145-w","article-title":"Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"2026060811114821100_bib8","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41586-024-08087-4","article-title":"Tumour evolution and microenvironment interactions in 2D and 3D space","volume":"634","author":"Mo","year":"2024","journal-title":"Nature"},{"key":"2026060811114821100_bib9","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"2026060811114821100_bib10","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1038\/s41467-021-25962-0","article-title":"Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer","volume":"12","author":"Hammerl","year":"2021","journal-title":"Nat Commun"},{"key":"2026060811114821100_bib11","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026060811114821100_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2026060811114821100_bib13","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026060811114821100_bib14","doi-asserted-by":"crossref","first-page":"lqae138","DOI":"10.1093\/nargab\/lqae138","article-title":"Exploring public cancer gene expression signatures across bulk, single-cell and spatial transcriptomics data with signifinder Bioconductor package","volume":"6","author":"Pirrotta","year":"2024","journal-title":"NAR Genom Bioinform"},{"key":"2026060811114821100_bib15","article-title":"pheatmap: pretty heatmaps","author":"Kolde","year":"2025"},{"key":"2026060811114821100_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-0716-0301-7_7","article-title":"Profiling cell type abundance and expression in bulk tissues with CIBERSORTx","volume":"2117","author":"Steen","year":"2020","journal-title":"Methods Mol Biol"},{"key":"2026060811114821100_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41467-022-28020-5","article-title":"Advances in mixed cell deconvolution enable quantification of cell types in spatial transcriptomic data","volume":"13","author":"Danaher","year":"2022","journal-title":"Nat Commun"},{"key":"2026060811114821100_bib18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/bioinformatics\/btv693","article-title":"Genefu: an R\/Bioconductor package for computation of gene expression-based signatures in breast cancer","volume":"32","author":"Gendoo","year":"2016","journal-title":"Bioinformatics"},{"key":"2026060811114821100_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4137\/CIN.S9983","article-title":"TNBCtype: a subtyping tool for triple-negative breast cancer","volume":"11","author":"Chen","year":"2012","journal-title":"Cancer Inform"},{"key":"2026060811114821100_bib20","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/ar.24086","article-title":"Genetic disorders of the extracellular matrix","volume":"303","author":"Lamand\u00e9","year":"2020","journal-title":"Anat Rec (Hoboken)"},{"key":"2026060811114821100_bib21","first-page":"784","article-title":"Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer","volume":"21","author":"Zhu","year":"2024","journal-title":"Cancer Biol Med"},{"key":"2026060811114821100_bib22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1158\/1078-0432.CCR-19-1773","article-title":"Comprehensive profiling of poor-risk paired primary and recurrent triple-negative breast cancers reveals immune phenotype shifts","volume":"26","author":"Hutchinson","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2026060811114821100_bib23","doi-asserted-by":"crossref","first-page":"e2000368","DOI":"10.1200\/PO.20.00368","article-title":"Changes in triple-negative breast cancer molecular subtypes in patients without pathologic complete response after neoadjuvant systemic chemotherapy","volume":"6","author":"Masuda","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"2026060811114821100_bib24","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41385-021-00427-1","article-title":"Granzyme B prevents aberrant IL-17 production and intestinal pathogenicity in CD4+ T cells","volume":"14","author":"Hoek","year":"2021","journal-title":"Mucosal Immunol"},{"key":"2026060811114821100_bib25","first-page":"575","article-title":"[The expressional characteristics and diagnostic values of TRBC1 in mature T-cell lymphoma]","volume":"43","author":"Zhang","year":"2022  14","journal-title":"Chin J Hematol"},{"key":"2026060811114821100_bib26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s42003-024-06563-1","article-title":"Oligoclonal CD4+CXCR5+ T cells with a cytotoxic phenotype appear in tonsils and blood","volume":"7","author":"Liang","year":"2024","journal-title":"Commun Biol"},{"key":"2026060811114821100_bib27","doi-asserted-by":"crossref","first-page":"eaan8664","DOI":"10.1126\/sciimmunol.aan8664","article-title":"Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis","volume":"3","author":"Patil","year":"2018","journal-title":"Sci Immunol"},{"key":"2026060811114821100_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yexcr.2004.07.001","article-title":"Syndecan-1 ectodomain regulates matrix-dependent signaling in human breast carcinoma cells","volume":"300","author":"Burbach","year":"2004","journal-title":"Exp Cell Res"},{"key":"2026060811114821100_bib29","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1159\/000491060","article-title":"Gremlin1 delivered by mesenchymal stromal cells promoted epithelial-mesenchymal transition in human esophageal squamous cell carcinoma","volume":"47","author":"Hong","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2026060811114821100_bib30","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1186\/s12885-018-4772-0","article-title":"Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer","volume":"18","author":"Andriani","year":"2018","journal-title":"BMC Cancer"},{"key":"2026060811114821100_bib31","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/ijc.33687","article-title":"Identification of calmodulin-like protein 5 as tumor-suppressor gene silenced during early stage of carcinogenesis in squamous cell carcinoma of uterine cervix","volume":"149","author":"Kitazawa","year":"2021","journal-title":"Int J Cancer"},{"key":"2026060811114821100_bib32","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1038\/s41467-021-26271-2","article-title":"Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions","volume":"12","author":"Andersson","year":"2021","journal-title":"Nat Commun"},{"key":"2026060811114821100_bib33","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat Genet"},{"key":"2026060811114821100_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/0008-5472.CAN-22-2682","article-title":"Spatial transcriptomic analysis of a diverse patient cohort reveals a conserved architecture in triple-negative breast cancer","volume":"83","author":"Bassiouni","year":"2023","journal-title":"Cancer Res"},{"key":"2026060811114821100_bib35","doi-asserted-by":"crossref","first-page":"e2205395","DOI":"10.1002\/advs.202205395","article-title":"Combined single-cell and spatial transcriptomics reveal the metabolic evolvement of breast cancer during early dissemination","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"2026060811114821100_bib36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.tranon.2018.11.008","article-title":"Quadruple Negative Breast Cancers (QNBC) demonstrate subtype consistency among primary and recurrent or metastatic breast cancer","volume":"12","author":"Angajala","year":"2019","journal-title":"Transl Oncol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0808\/3793325\/crc-25-0808.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/5\/1246\/3798057\/crc-25-0808.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/5\/1246\/3798057\/crc-25-0808.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:12:08Z","timestamp":1780931528000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/5\/1246\/785468\/TNBC-Spatial-Transcriptomic-Analysis-across"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0808","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.32507989","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32605327","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32605339","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32507992","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32605336","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32508013","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32508025","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32508004","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32508016","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32605324","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32605321","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32508028","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32508007","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32507995","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32605333","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32507998","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32605330","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32508019","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32508010","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32508022","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32508001","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8505877","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}